Evidence map›Paper›PMID 32880686›Full record

ArticleDiabetologia2020

Adiponectin treatment improves insulin resistance in mice by regulating the expression of the mitochondrial-derived peptide MOTS-c and its response to exercise via APPL1-SIRT1-PGC-1α.

Qi Guo, Bo Chang, Qiong-Li Yu, Si-Tong Xu, Xue-Jie Yi, Shi-Cheng Cao

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Diabetologia, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Associations Between Adiponectin and the Development of Diabetes in Rheumatoid Arthritis.The Journal of clinical endocrinology and metabolism · 2024
    Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Qi GuoDepartment of Sports Medicine, China Medical University, Shenyang, China.
Bo ChangExercise and Health Research Center/Department of Kinesiology, Shenyang Sport University, Shenyang, China.
Qiong-Li YuDepartment of Sports Medicine, China Medical University, Shenyang, China.
Si-Tong XuExercise and Health Research Center/Department of Kinesiology, Shenyang Sport University, Shenyang, China.
Xue-Jie YiExercise and Health Research Center/Department of Kinesiology, Shenyang Sport University, Shenyang, China. yixuejie8387@163.com.
Shi-Cheng CaoDepartment of Sports Medicine, China Medical University, Shenyang, China. Caoshicheng6666@163.com.ORCID 0000-0002-3502-557X
China Medical University · CNShenyang Sport University · CN

Funding

National Natural Science Foundation of China No. 30971414
6 · The paper itself

Abstract

aims/hypothesisAdiponectin stimulates mitochondrial biogenesis through peroxisome proliferator-activated receptor-γ coactivator 1α (PGC-1α), a major regulator of mitochondrial biogenesis. MOTS-c (mitochondrial open reading frame of the 12S rRNA) is a biologically active mitochondrial-derived peptide encoded by mitochondrial DNA. It influences the mechanisms of obesity and diabetes. We hypothesised that the adiponectin pathway may regulate the production and/or secretion of MOTS-c in skeletal muscle. We aimed to determine whether exercise and adiponectin affect MOTS-c to improve insulin resistance in mice.

methodsTo investigate this hypothesis, we used wild-type C57BL/6 mice subjected to high-fat diet, an exercise regimen, and i.p. injection of recombinant mouse adiponectin (Acrp30) or MOTS-c, and adiponectin knockout (Adipoq

resultsIn Adipoq CONCLUSIONS/

interpretationOur findings showed that the APPL1-SIRT1-PGC-1α pathway regulates the production and/or secretion of skeletal muscle MOTS-c by mediating adiponectin signalling. Our study provides an insight into the cellular and molecular pathways underlying the pathogenesis of diabetes and shows that MOTS-c is a potential novel therapeutic target in the treatment of diabetes. Graphical abstract.

Indexed as

Adaptor Proteins, Signal TransducingAdiponectinAnimalsInsulin ResistanceMiceMice, Inbred C57BLModels, BiologicalMuscle, SkeletalPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaSirtuin 1Transcription FactorsAdaptor Proteins, Signal TransducingAdiponectinAppl1 protein, mousePeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaPpargc1a protein, mouseSirtuin 1Transcription FactorsAdiponectinDiabetesExercise-mediated signallingMitochondrial biogenesisMOTS-cSkeletal muscle

Identifiers

PMID32880686
OpenAlexW3083650688

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.